These results, along with a preceding report showing that a little-molecule ACKR3 agonist CCX771 reveals anxiolytic-like actions in mice,2 support the principle of focusing on ACKR3 as a novel solution to modulate the opioid process, which could open up new therapeutic avenues for opioid-associated Issues. Disclaimer: The above mentioned https://annelib267jzw1.blogthisbiz.com/profile